SILVERARC CAPITAL MANAGEMENT, LLC
Position in CLDX — Celldex Therapeutics, Inc.
CIK 1816307
BOSTON, MA
Position in CLDX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$5,658,150
+$468,581 QoQ
Shares Held
178,378
-6.6% QoQ
Ownership
0.227%
of shares outstanding
% of Portfolio
0.77%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CLDX Over Time
Shares Held
Position Value (USD)
Derivatives in CLDX
reported options exposure · as of Jun 30, 2022CallValue
$0
CallShares
0
PutValue
$970,560
PutShares
36,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026SILVERARC CAPITAL MANAGEMENT, LLC holds $802,586,993 across 53 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
206,234 | $55,006,732 | |
| 2 | CELC |
Celcuity Inc.
|
500,996 | $52,414,201 | |
| 3 | COGT |
Cogent Biosciences, Inc.
|
1,280,707 | $49,563,360 | |
| 4 | URGN |
UroGen Pharma Ltd.
|
1,301,979 | $47,912,827 | |
| 5 | IMNM |
Immunome Inc.
|
2,017,009 | $42,740,420 | |
| 6 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
390,000 | $38,017,200 | |
| 7 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
311,461 | $34,581,514 | |
| 8 | ORKA |
Oruka Therapeutics, Inc.
|
352,802 | $33,576,166 |
All Filings in CLDX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,658,150 | 178,378 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $5,189,569 | 191,074 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $9,026,612 | 348,922 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $4,038,274 | 198,441 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,738,210 | 205,962 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $6,685,431 | 264,560 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,928,550 | 145,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $13,875,419 | 374,910 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $12,562,292 | 299,316 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $9,804,546 | 247,215 | Shares | Sole | 2024-02-14 | |
| 2023-06-30 | $339,300 | 10,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,045,742 | 84,651 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,437,934 | 54,699 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,497,560 | 53,275 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $979,241 | 36,322 | Shares | Sole | 2022-07-25 | |
| 2022-06-30 | $970,560 | 36,000 | Put | Sole | 2022-07-25 | |
| 2022-03-31 | $256,000 | 45,538 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,743,900 | 45,132 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,064,739 | 38,243 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $331,758 | 9,921 | Shares | Sole | 2021-08-16 | |
| 2020-12-31 | $1,406,540 | 80,282 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||